| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
1 |
| Employees |
43 |
| Revenues (TTM) (Millions $) |
-8 |
| Net Income (TTM) (Millions $) |
-39 |
| Cash Flow (TTM) (Millions $) |
-16 |
| Capital Exp. (TTM) (Millions $) |
1 |
Business Description
Biocept Inc is a publicly-traded molecular diagnostics company based in San Diego, California, which specializes in developing liquid biopsy tests to improve the detection and monitoring of various types of cancer.
The company was founded in 1997 and went public in 2014 on the NASDAQ stock exchange under the symbol "BIOC". Since then, Biocept has become a trusted leader in the field of liquid biopsy testing, allowing physicians to analyze circulating tumor cells (CTCs), cell-free DNA (cfDNA), and other cancer biomarkers in the bloodstream. This approach enables doctors to make more informed decisions about cancer diagnoses, treatment plans, and monitoring.
Biocept's proprietary technology platform is called Target Selector, which is designed to capture and analyze rare cells and fragments of cancer DNA circulating in patients' blood. The company's liquid biopsy tests are used to detect, diagnose, and monitor various types of cancer, including lung, breast, colorectal, gastric, prostate, and melanoma.
In addition to its liquid biopsy tests, Biocept also offers a variety of other biomarker assays, including tests for HER2, estrogen receptor (ER), progesterone receptor (PR), androgen receptor (AR), and more. These assays help doctors to guide targeted cancer therapies and monitor patients' responses to treatment.
Biocept has partnerships with major healthcare providers worldwide, including Quest Diagnostics and the University of Texas MD Anderson Cancer Center. The company also works closely with pharmaceutical companies to develop companion diagnostic tests for their cancer drugs.
Overall, Biocept is committed to advancing the diagnosis and treatment of cancer through innovative liquid biopsy testing, cutting-edge technology, and strategic partnerships with healthcare providers and pharmaceutical companies. The company's mission is to improve patient outcomes and enhance the quality of life for those affected by cancer.
Company Address: 9955 Mesa Rim Road San Diego 92121 CA
Company Phone Number: 320-8200 Stock Exchange / Ticker: NASDAQ BIOC
|
%
0.29%